Cost-effectiveness analysis of the first line treatment of hepatocellular carcinoma with lenvatinib and sorafenib

WANG Jingwen, DONG Zuojun, ZHOU Xiaoying, SUN Guojun

Shanghai Medical & Pharmaceutical Journal ›› 2023, Vol. 44 ›› Issue (1) : 44-47.

PDF(1965 KB)
主管单位：上海市经济和信息化委员会
主办单位：上海医药行业协会
中国标准连续出版物号：
ISSN 1006-1533
CN 31-1663/R
PDF(1965 KB)
Shanghai Medical & Pharmaceutical Journal ›› 2023, Vol. 44 ›› Issue (1) : 44-47.
MEDICINE & CLINIC

Cost-effectiveness analysis of the first line treatment of hepatocellular carcinoma with lenvatinib and sorafenib

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 44(1): 44-47

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1965 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Shanghai Medical & Pharmaceutical Journal, All Rights Reserved.
Powered by Powered by Beijing Magtech Co. Ltd,.

/

〈 〉